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Abstract
We have identified and cloned a cDNA encoding a new member of the monooxygenase family of enzymes. This novel enzyme,
which we call MOX (monooxygenase X; unknown substrate) is a clear sequence homologue of the enzyme dopamine b-hydroxylase
(DBH). MOX maintains many of the structural features of DBH, as evidenced by the retention of most of the disulfide linkages
and all of the peptidyl ligands to the active site copper atoms. Unlike DBH, MOX lacks a signal peptide sequence and therefore
is unlikely to be a secreted molecule. The steady-state mRNA levels of MOX are highest in the kidney, lung, and adrenal gland,
indicating that the tissue distribution of MOX is broader than that of DBH. Antisera raised to a fusion protein of MOX identifies
a single band of the expected mobility by Western blot analysis. MOX mRNA levels are elevated in some fibroblast cell strains
at replicative senescence, through this regulation is not apparent in all primary cell strains. The gene for MOX resides on the q
arm of chromosome 6 and the corresponding mouse homolog has been identified. © 1998 Elsevier Science B.V. All rights reserved.
Keywords: monooxygenase; CDNA; senescence; chromosomal localization
1. Introduction Stachowiak et al., 1990a) and calcium (Stachowiak et al.,
1990b). Since DBH catalyses the conversion of a mole-
Dopamine b-hydroxylase (DBH) catalyses a key step cule that lowers blood pressure (dopamine) into one
in catecholamine biosynthesis; the conversion of dopa- that elevates blood pressure (noradrenaline), inhibition
mine to norepinephrine ( Kaufman and Goldstein, 1965) of this enzyme has been targeted as a means of treating
and is widely conserved amongst mammals. The enzyme hypertension ( Kruse et al., 1986; Li et al., 1996). In
is expressed in noradrenergic and adrenergic neurons of humans, genetic DBH deficiency results in profound
the central nervous system, as well as the chromaYn orthostatic hypotension (Robertson et al., 1991), and
cells of the adrenal medulla (Axelrod, 1972). DBH in mice, targeted disruption of DBH results in embryonic
mRNA levels are aVected by growth factors (Hwang lethality (Thomas et al., 1995). Interestingly, DBH-
and Choi, 1995), cyclic AMP (Lewis et al., 1987; deficient embryos can be rescued by adrenergic agonists,
or a synthetic precursor of noradrenaline, but upon
reaching adulthood, these mice display impaired mater-* Corresponding author. Tel: +1 650 473 7730; Fax: +1 650 473 7750;
nal behaviour (Thomas and Palmiter, 1997). Thus,e-mail: wfunk@geron.com
1 Present address: Gronigen Biomolecular Sciences and Biotechnology DBH activity plays an important role in embryonic
Institute University of Gronigen, Nijenborgh 4, 9747 AG Groningen, development and in adult behaviour.
The Netherlands. DBH shares homology with the monooxygenase
domain of the bi-functional enzyme peptidyl-glycineAbbreviations: cAMP, adenosine 5∞-3∞-cyclomonophosphate; DBH,
dopamine b-hydroxylase; EST, expressed sequence tag; GST, glutathi- amidating monooxygenase (PAM) (Eipper et al., 1992).
one S-transferase; HEK, human embryonic kidney; HUVEC, human Both enzymes catalyze two-electron monooxygenation
umbilical vein endothelial cell; MOX, monooxygenase X; PAGE, poly- reactions that are ascorbate-dependent and involve the
acrylamide gel electrophoresis; PAM, peptidylglycine a-amidating
stereospecific replacement of a methylene hydrogen bymonooxygenase; PDL, population doubling level; RT–PCR, reverse
transcriptase–polymerase chain reaction; UTR, untranslated region. hydroxyl ( Klinman, 1996). The recent description of
0378-1119/98/$19.00 © 1998 Elsevier Science B.V. All rights reserved.
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the crystal structure of the monooxygenase domain of consensus cDNA sequence has been deposited in the
American Type Culture Collection (ATCC ).PAM clearly shows two subdomains, each containing a
copper atom bound by peptidyl side-chain ligands
(Prigge et al., 1997). DBH and PAM have distinct 2.2. Cell strains
substrate preferences (dopamine for DBH, petidylglyc-
ine for PAM), but both enzymes display activity to a Normal diploid human cell strains were grown in
rather broad range of substrates ( Klinman, 1996). humidified incubators at 37°C at 5% CO2. BJ fibroblastsCo-crystallization of the monoxygenase domain of PAM were provided by Jerry Shaw (University of Texas,
with a synthetic substrate reveals that the substrate is Southwestern Medical Center at Dallas). C4 and MA
bound primarily through hydrogen bonds at the active fibroblasts strains were established from human skin
site, while the peptide side chains are held by non- samples and human umbilical vein endothelial cells
specific contacts, thus providing a rationale for the (HUVECs) were obtained from the ATCC. Cells were
broad permissiveness of the enzyme with regards to passaged serially and population doubling levels (PDL)
substrate (Prigge et al., 1997). were determined by split ratios. For BJ fibroblasts, early
We have investigated the alteration of gene expression passage cells were defined as PDL 25–35, late passage
patterns that accompanies replicative senescence in cells were PDL 90–93. For C4 fibroblasts, early passage
normal human cell strains using a modified version of cells were defined as PDL 20–30, late passage cells were
the diVerential display technique and have catalogued PDL 48–50. For MA fibroblasts, early passage cells
many genetags that are dysregulated at senescence were defined as PDL 10–15, late passage cells were PDL
(Linskens et al., 1995). One of several cDNAs identified 48–50. For HUVECs, early passage cells were defined
by this study is reported here and encodes a novel as PDL 15–25, late passage cells were PDL 50–52.
homolog of DBH.
2.3. Northern blot
A total RNA blot from human tissues was obtained2. Materials and methods
(Northern Territory, Invitrogen, San Diego, CA, USA)
and probed with a random-hexamer primed-,2.1. cDNA isolation and analysis
32P-labeled MOX cDNA fragment (nucleotides
1514–1839) according to the manufacturer’s instruc-Genetags whose expression levels were altered in
tions. The blot was exposed to a Phosphor Imagersenescent human fibroblasts (Linskens et al., 1995) were
screen (Molecular Dynamics, Sunnyvale, CA) for 2used as hybridization probes to identify homologous
days.clones from a cDNA library prepared from BJ human
foreskin fibroblast poly A+ mRNA (Lark Technologies,
Houston, TX ). The cDNA inserts of these clones were 2.4. RT–PCR
isolated by restriction digestion, sonicated to an average
size of 500 bp and subcloned into pBluescript II Total RNA from cell lines was prepared as described
(Linskens et al., 1995). Total RNA samples from tissues(Stratagene, La Jolla, CA, USA). DNA sequence analy-
sis was obtained using an ABI 377 automated fluores- were obtained from ClonTech (Palo Alto, CA, USA).
cDNA was prepared from total RNA using randomcence DNA sequencer (Perkin-Elmer Applied
Biosystems, Foster City, CA, USA) and the results were hexamer primers and SuperScript II reverse transcriptase
(Bethesda Research Laboratories, Bethesda, MD, USA)compiled using the GeneWorks and ABI Prism software
packages. as described (Feng et al., 1995). PCR was performed
using cDNA and GC6-specific primers in the presenceAnalysis of the sequences showed that one cDNA,
GC6, corresponding to the genetag GS6 (Linskens et al., of 32P-a-dATP. Parallel reactions were performed with
varying amounts of input cDNA to ensure the amplifi-1995), included an extended open reading frame (ORF)
that showed amino acid similarity to dopamine b- cations were within the linear range. Reaction products
were resolved using polyacrylamide gel electrophoresishydroxylase (DBH). The ORF extended from the 5∞-end
of clone GC6, indicating that the cDNA was not full- (PAGE) and then exposed to phosphorimager screens
(Molecular Dynamics). Similar reactions were per-length. Subsequently, a probe fragment was generated
using the PCR that corresponded to the 5∞-most sequence formed using 28S ribosomal RNA-specific primers.
Signal from the appropriate bands were quantified andof the cDNA. Screening of a l GT11 cDNA library
produced from HEK 293 cell mRNA with this probe the MOX signal was then normalized using the signal
from the corresponding 28S reaction. For all RT–PCRidentified a second clone (l 3-1-4). DNA sequence
analysis confirmed that l 3-1-4 extended the existing analyses, results are reported as the average of at least
three signals within the linear range of amplification.ORF and included a likely initiator Met codon. The
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2.5. Fusion protein and antisera production
A EcoRI restriction fragment (including nucleotides
286–1168; Fig. 1) was prepared from plasmid GC6 and
sub-cloned into the EcoRI site of the GST-fusion vector
pGEX-5X-3 (Pharmacia, Piscataway, NJ, USA). The
resulting plasmid, pGEX-GC6, was introduced into E.
coli strain DH5a. Bacterial cultures were then grown at
37°C in LB medium containing 100 mg/ml ampicillin to
an A600nm of approximately 0.5 and fusion protein
(GST–MOX ) expression was induced by the addition
of IPTG to a final concentration of 1 mM. The cultures
were continued for 6 h and the bacteria were collected
by centrifugation. The bacterial pellet was resuspended
in cold PBS and then sonicated briefly. Triton X-100
was added to a final concentration of 1% and the
suspension was shaken gently for 30 min. The suspension
was centrifuged briefly and the supernatant was
removed. The pellet, enriched for inclusion bodies, was
resuspended in PBS containing 1% sarkosyl, gently
mixed for 30 min, and centrifuged briefly (Burgess,
1996). The supernatant was collected and then dena-
tured by boiling in the presence of b-mercaptoethanol.
The sample was loaded onto preparative SDS–PAGE
gels (10% acrylamide; BioRad) and resolved at 30 mA
constant current. The fusion protein band was visualized
by briefly staining the gel with 0.1% Coomassie stain in
water, excised and then destained in water. The gel
fragment was macerated prior to injection into host
rabbits (Babco, Richmond, CA). Antisera was harvested
after a secondary antigen boost.
Attempts to bind the GST–MOX fusion protein to
GS-agarose were unsuccessful, thus precluding aYnity
purification of the antisera. Instead, a column matrix
was prepared to remove non-specific antibody activities
from the serum as follows. Cultures of bacteria hosting
the parental plasmid pGEX-5X-3 were prepared as
above and the 1% Triton X-100 supernatant was reco-
vered. This material was added to AYgel 15 matrix
(BioRad, Hercules, CA) and coupled overnight at 4°.
The coupled matrix was washed extensively with PBS
containing 1% Triton X-100 and then packed as a
column. Crude antisera was then passed over the column
and the flow-through re-applied. The column was
resolved with PBS and eluted fractions were assayed for
reactive antisera by Western blot analysis of extracts
from bacteria expressing the pGEX-GC6 vector. For
Western blot analysis, gel-purified GST–MOX was first
exchanged into factor Xa protease buVer (100 mM
NaCl, 50 mM Tris–HCl (pH 8.0), 1 mM CaCl2) and
cleaved according to the supplier’s instructions (New Fig. 1. cDNA sequence of MOX mRNA. DNA sequence analysis was
England Biolabs, Beverley, MA, USA). performed on overlapping MOX cDNA clones, providing a conceptual
translation of the protein. An in-frame stop codon in the 5∞-non-codingProtein extracts of whole cells were prepared and
sequence is boxed and potential polyadenylation signal sequences in20 mg of soluble protein were loaded onto SDS–PAGE
the 3∞-untranslated region are underlined.gels, resolved and transferred onto Nytran membranes
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Fig. 2. (A) Amino acid sequence comparison of human MOX (this study), DBH (translated from GenBank deposit X13255) and the monooxygenase
catalytic core of PAM (translated from Genbank deposit M37721). Sequences were aligned manually and residues shared between MOX and DBH
or MOX, DBH and PAM are boxed. e, Cys residues conserved in MOX, DBH and PAM; % Cys residues conserved only in MOX and DBH; $
Predicted peptidyl copper ligands. (B) Disulfide bridging patterns for MOX, DBH, and PAM. The disulfide bridging pattern for the human DBH
homodimer was inferred from the pattern assigned for bovine DBH (Robertson et al., 1994), and the human PAM pattern was inferred from that
of rat PAM ( Kolhekar et al., 1997). The pattern for MOX is proposed based on the conservation of Cys residues between DBH and MOX. (C)
Kyte–Doolittle plot comparison of MOX and DBH. Plots were generated using the GeneWorks 2.5 software package (Intelligenetics, Mountain
View, CA) and were then aligned as in (A).
(Schleicher and Schuell ). Blots were blocked in the TBS Tween 20, the secondary antibody (alkaline phospha-
tase-conjugated goat-anti rabbit IgG, Gibco/BRL,buVer containing 0.1% Tween 20 and 5 mg/ml of non-
fat powdered milk. Purified anti-MOX antisera was Gaithersburg, MD, USA) was applied at a 1:1000
dilution in block solution. NBT/BCIP (Gibco/BRL) wasapplied at a 1:500 dilution in the block solution.
Following serial washes in TBS buVer containing 0.1% used to develop the blot.
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Fig. 2. (continued).
2.6. Radiation hybrid panel mapping 3. Results
GC6-specific primers were used for PCR with genomic 3.1. cDNA cloning and DNA sequence analysis
DNA from the Stanford G3 RH Panel (Research
Genetics, Huntsville, AL). The PCR products were Our initial diVerential display catalog of senescence-
dysregulated genes from human diploid fibroblasts con-resolved on agarose gels and scored for identity with
the same reaction performed on pMOX plasmid DNA. tained both known and novel genetag sequences
(Linskens et al., 1995). We isolated one clone, GC6,The results were tabulated and processed through the
radiation hybrid server at the Standford Human that corresponded to the original genetag GS6. GC6
encoded an extensive open reading frame that sharedGenome Center (rhserver@shgc.standford.edu).
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significant homology with dopamine b-hydroxylase The recent description of the crystal structure of the
monooxygenase domain of peptidylglycine a-hydroxyl-(DBH), an enzyme that converts dopamine to norepi-
nephrine (Lamouroux et al., 1987). We have called the ating monooxygenase (PAM) (Prigge et al., 1997) has
confirmed many of the predicted structural features ofpredicted protein MOX (monooxygenase X: unknown
substrate). The isolation of an additional clone, l 3-1-4, this enzyme, such as peptidyl copper ligands and the
placement of residues that contribute to catalytic activitygenerated a longer cDNA encoding an extensive open
reading frame (ORF) (Fig. 1) The cDNA contains a ( Kolhekar et al., 1997; Boswell et al., 1996; Eipper et al.,
1992; Yonekura et al., 1996). MOX maintains all of thelikely initiator Met, based on the occurrence of an
upstream, in-frame, stop codon. In vitro transcrip- peptidyl copper ligands seen in PAM, as does DBH
(Fig. 2A). Thus, MOX is predicted to display monooxy-tion–translation of this cDNA provides a protein whose
mobility is consistent with this assignment (data not genase activity. A co-crystal structure of PAM with
substrate also identified several residues that interactedshown). The sequence surrounding this codon appears
to be a relatively weak match to a derived initiator directly with substrate. Only one of these substrate
interacting residues (PAM Y318), is conserved in DBHconsensus sequence (MOX: AGGTCCTATGA
Consensus: GCCAGCCATGG; Kozak, 1987). To verify (Y477) and MOX (Y400). In PAM, this residue anchors
the terminal carboxyl of the substrate at the active sitethe sequence in this region, we performed RT–PCR on
total RNA from BJ fibroblasts using MOX-specific and mutations in this residue increase Km but do not
aVect Vmax, a result consistent with a role in substrateprimers that flank the proposed initiator codon. DNA
sequence analysis of the resulting PCR products con- binding ( Kolhekar et al., 1997). In DBH, the native
substrate (dopamine) lacks a terminal carboxyl, thoughfirmed the length of the open reading frame and the
presence of upstream stop codons. Within the 3∞ UTR one might predict in this case that the residue serves to
anchor the terminal amine.of the message, multiple consensus polyadenylation sig-
nals are apparent (Fig. 1). The overall DNA sequence The most striking diVerence noted between the pri-
mary sequences of DBH and MOX is the lack of aidentity between human DBH and MOX is low (25%).
Since these proteins share obvious homology, the evolu- signal peptide sequence at the N-terminus of MOX
(Fig. 2C) and thus MOX is unlikely to be secreted. Thetionary rooting of these two genes must be deep. A
BLAST search of the mouse EST database identified signal sequence of DBH has been investigated extens-
ively and both cleaved and uncleaved versions of thecorresponding sequences for mouse MOX (ESTs
AA388297, AA068006, AA199428), and a contig of DBH molecule have been identified, as have soluble and
membrane-bound forms of the enzyme ( Winkler et al.,these ESTs shares 84% DNA sequence identity and 88%
amino acid sequence identity with human MOX (span- 1970; Dhawan et al., 1987; Lewis and Asnani, 1992).
The 5∞-untranslated region of the MOX mRNA mayning nucleotides 784–1289 of the human MOX mRNA)
(data not shown). have a cryptic signal peptide sequence that has been
interrupted by a stop codon, suggesting that MOX may
have originated from a gene that, like DBH, encoded a3.2. Amino acid sequence comparisons
signal peptide.
The predicted amino acid sequence of MOX is clearly
homologous to human DBH, as shown in Fig. 2. The 3.3. mRNA expression patterns
DBH monomer is characterized by structural features
that include the presence of multiple disulfide bonds Northern blot analysis of total RNA from
BJ fibroblasts indicates a major MOX transcript ofthat have been assigned by peptide analysis of the bovine
enzyme (Robertson et al., 1994). Most of these Cys approximately 3.3 kb (Fig. 3A). An examination of the
3∞-non-coding region of the MOX cDNA revealsresidues are conserved in MOX (Fig. 2B), though two
Cys residues proposed to form intermolecular bonds in multiple polyadenylation sites (AATAAA) (Fig. 1),
however, we cannot at present determine with precisionDBH (Cys 514 and 516 in the human enzyme) are
absent in MOX, and two non-homologous Cys residues the preferred sequence. The relative expression of MOX
transcripts appeared highest in lung, kidney and brain.are found at the C-terminus of MOX. Further biochemi-
cal characterization of the MOX protein will be required RT–PCR analysis confirmed high levels in the kidney
and lung and also suggested modest expression in theto determine if these C-terminal Cys residues form a
novel disulfide bond, or form intermolecular bonds, as testes (Fig. 3B). To extend this analysis, a dot blot of
total RNA (ClonTech, Palo Alto, CA, USA) from ais the case with DBH. A further subset of Cys residues
is conserved across the catalytic core of MOX, DBH wide variety of human tissues was probed; the results
confirmed high levels of MOX expression in lung andand PAM, suggesting that the overall architecture of
these cores is similar. Over this region, MOX and DBH kidney and also showed high levels of expression in fetal
kidney, uterus and adrenal gland tissues (data notshare approximately 40% amino acid identity, while
MOX and PAM share 23% identity. shown). Protein analysis has consistently demonstrated
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that DBH expression is restricted to adrenergic and
noradrenergic cells of the adrenal gland, and the central
and peripheral nervous system. EST expression data
from the UniGene set (http://www.ncbi.nlm.nih.
gov/Schuler/UniGene/Hs.Home.html ) confirm that
DBH is expressed predominantly in adrenal tissues.
To determine the expression of MOX mRNA in
senescent human cell strains, RT–PCR was performed
on total RNA samples. As seen in Fig. 3C, MOX
mRNA levels were significantly higher in senescent
BJ foreskin fibroblasts compared with early passage
cultures, similar to the pattern we had observed pre-
viously for the original genetag GS6 (Linskens et al.,
1995). This up-regulation was most pronounced in low
serum conditions (0.5% FBS). A similar pattern of
expression was also seen in MA dermal fibroblasts.
However, in C4 dermal fibroblasts expression levels were
highest in early passage cultures in high serum. In
HUVEC cells, a vascular endothelial cell type, expres-
sion patterns were similar to those seen in BJ fibroblasts,
although absolute expression levels were significantly
lower than in fibroblast strains. Thus, changes in the
steady-state levels of MX mRNA are associated with
replicative senescence in at least two cell types, and in
two strains of the same cell type (BJ and MA skin
fibroblasts).
3.4. Protein expression levels
A rabbit polyclonal antisera was raised against a
glutathione S-transferase–MOX fusion protein and was
used to assess MOX protein levels in human cell lines.
As seen in Fig. 4, the antisera specifically recognizes a
protein of approximately the predicted mobility of MOX
(62.6 kDa). The expression levels appeared high in many
of the cell lines tested. Using a partially purified source
of bovine DBH, we were unable to detect cross-reactivity
using the anti-MOX antisera, thus confirming the speci-
ficity of the reagent (data not shown).
3.5. Chromosomal localization
A radiation-hybrid panel was used to map the chro-
mosomal localization of the MOX gene. MOX-specific
primers were initially tested to identify pairs that could
skeletal muscle. (B) RT–PCR analysis of human tissues. Total RNA
from human tissues as the starting material (Clontech). RT–PCR
analysis was performed on total RNA (Clontech), using cDNA pro-
duced with random hexamer-primed total RNA. Expression levels for




2.4). (C) RT–PCR analysis of senescent human cells. RT–PCR wasFig. 3. Expression of MOX MRNA in human cells and tissues. (A)
performed as for (B). MOX signals are reported as relative expressionNorthern blot analysis of human tissues. A Northern blot of total
levels from early passage cells (E) or late passage cells (L). HumanRNA (Invitrogen) from human tissues was probed with 32P-labeled
fibroblast strains: BJ, C4 and MA; human umbilical vein endothelialMOX probe (Section 2.3). Lane 1: heart; lane 2: brain; lane 3: kidney;
cells: HUVEC; e, high serum conditions; & low serum conditions.lane 4: liver; lane 5: lung; lane 6: pancreas; lane 7: spleen; lane 8:
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4. Discussion
We have identified and performed an initial character-
ization of a homolog of dopamine b-hydroxylase. Our
results indicate that the steady-state mRNA levels of
MOX are upregulated in some strains of cultured normal
human cells at replicative senescence and that the expres-
sion pattern in human tissue partially overlaps with the
patterns reported for DBH.
Fig. 4. Western blot analysis of MOX. Protein extracts (10 mg total )
from various human cell lines were resolved by SDS–PAGE, transfer- 4.1. Homology with other monooxygenases
red to membranes, then probed with purified anti-MOX antisera. A
preparation of Factor Xa-cleaved GST–MOX was included at various The unexpected identification of a clear homolog ofconcentrations. Lane 1: adenovirus transformed embryonal kidney
DBH is interesting in view of the large number of studiescells (HEK 293); lane 2: renal adenocarcinoma (ACHN); lane 3: epi-
that have investigated DBH biochemistry and function.dermoid carcinoma (A-431); lane 4: breast adenocarcinoma (MCF7);
lane 5: bread adenocarcinoma (MDA); lane 6: squamous cell carci- Clearly, MOX can be assigned monooxygenase function
noma (Scc61-S9); lanes 7, 8, 9: factor Xa-cleaved GST–MOX at due to the absolute retention of peptidyl copper ligands,
approximately 10, 100 and 1000 pg, respectively. Uncleaved structural features such as Cys residues and overallGST–MOX (61 kDa) and cleaved partial polypeptide MOX (24 kDa)
sequence identity with both DBH and PAM. However,are indicated.
the substrate specificity of MOX will be an important
issue to resolve. DBH and PAM have relatively broad
but distinct substrate specificities, with DBH preferring
amplify an appropriately sized fragment from human phenylethylamines, while PAM acts on glycyl extended
genomic DNA, thus indicating that the primer pair prohormones. The co-crystal structure of the monooxy-
interval did not span an intervening sequence. Analysis genase domain of PAM bound with a substrate peptide
of the G3 radiation hybrid panel indicates that MOX shows that the protein interacts with substrate primarily
localizes to chromosome 6q, with a lod score of 10.8 through hydrogen bonds to the substrate peptide back-
for linkage to marker D6S413 (Fig. 5). We are presently bone. This relatively weak interaction may provide a
unaware of human genetic diseases that map tightly to structural basis for the wide substrate compatibility of
this locus. the enzyme (Prigge et al., 1997). The conservation of at
least one substrate-binding residue in MOX, PAM and
DBH (Y400 in hMOX, Y477, hDBH and Y318 in rat
PAM) suggests similarity in binding at the active sites.
We have performed some initial experiments to
express recombinant forms of MOX in eukaryotic cells
for the purpose of testing for catalytic activity. In vitro
transcription–translation of the MOX cDNA provides
a protein of the predicted mobility that was inactive in
a DBH activity assay (data not shown) (Li et al., 1996).
Expression of active recombinant DBH enzyme has
been reported (Lewis and Asnani, 1992; Gibson et al.,
1993, Li et al., 1996) and may prove instructive in the
expression of MOX for further analysis of the catalytic
activity. Alternatively, the antisera generated in this
study could be used to purify the native enzyme from
cell or tissue sources.
The absence of an obvious signal sequence for MOX
suggests that the protein may be retained intracellularly.
The signal sequence of DBH has been the focus of
numerous investigations. Uncleaved versions of DBH
that retain their signal peptides have been identified
(Robertson et al., 1990; Wang et al., 1990) and sugges-
Fig. 5. Chromosomal localization. The chromosomal location of MOX tions have been advanced that the association of the
was determined by using radiation hybrid panel mapping (Section 2.5).
protein with membranes is mediated through the remain-The closest marker was determined to be D6S413, on the long arm of
ing signal peptide (Taljanidisz et al., 1989). Other studieschromosome 6. The estimated distance from D6S413 to MOX is indi-
cated (1 cR=26 kb) with the lod score in parentheses. have shown that recombinant versions of DBH that
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lack a signal peptide are still capable of associating with in either cells or mice may be instructive in defining
additional biological roles for the enzyme.membranes (Lewis and Asnani, 1992; Gibson et al.,
1993), and thus in a similar manner, MOX may also
associate with membranes, even in the absence of a well-
defined signal peptide sequence. We note a region of Acknowledgement
predicted hydrophobicity at the extreme C-terminus of
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